Floatz logo

5-Flucytosine

Neoplasms, Brain

CHA UniversityPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Neoplasms, Brain cohort.

Asset / SponsorPhaseRating
msc11fcd
CHA University
Phase 1/2CCC
Dabrafenib
Novartis Pharmaceuticals
Phase 1/2CCC
G 207
M.D. Anderson Cancer Center
Phase 1CC

Same molecule, other indications

5-Flucytosine is also rated in:

Adult GliosarcomaDormant
CCC
Indicative ·
52 / 100
View asset →
Neoplasms, Germ Cell and EmbryonalDormant
CCC
Indicative ·
52 / 100
View asset →
glioblastomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →